Our Leadership Team Bristol Myers Squibb

Our Leadership Team - Bristol Myers Squibb.

She joined Bristol Myers Squibb in 2018 as vice president, Strategic Sourcing and Procurement, Global Product Development and Supply, managing a complex supply chain need to ensure the uninterrupted supply of medicines to our patients. Prior to joining Bristol Myers Squibb, she was with Pfizer for 18 years in a number of leadership positons..

https://www.bms.com/about-us/leadership/leadership-team.html.

The Bristol Myers Squibb Foundation.

The Bristol Myers Squibb Foundation brings together partners from the government, nonprofit, academic and private sectors to test innovations in health equity. We support programs that demonstrate the effectiveness of health system strengthening and community engagement to ensure that all patients can obtain high-quality healthcare regardless ....

https://www.bms.com/about-us/responsibility/bristol-myers-squibb-foundation.html.

Our Research and Development Team - Bristol Myers Squibb.

Learn more about the backgrounds, scientific pursuits and personal interests of members of our R&D team. These individuals are committed to pursuing Bristol Myers Squibb's goal of discovering, developing and delivering transformational medicines to patients..

https://www.bms.com/researchers-and-partners/our-r-and-d-team.html.

About Us - Bristol Myers Squibb.

At Bristol Myers Squibb, we work every day to transform patients' lives through science. We combine the agility of a biotech with the reach and resources of an established pharmaceutical company to create a global leading biopharma company powered by talented individuals who drive scientific innovation..

https://www.bms.com/about-us.html.

Our Board of Directors - Bristol Myers Squibb.

Elected annually by our shareholders, the Board of Directors is the company's ultimate decision-making body. The directors select and monitor the performance of our senior executives on Bristol Myers Squibb's Leadership Team, who are responsible for the day-to-day operation of the company.Directors also act as advisors and counselors to our senior management..

https://www.bms.com/about-us/leadership/board-of-directors.html.

Global Biopharmaceutical Company - Bristol Myers Squibb.

May 27, 2022 . Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases. ... Business Development Leadership Team Begin a Discussion Global Alliances leadership team ... scientific pursuits and personal interests of members of our research team..

https://www.bms.com/.

Our Mission, Vision, Values & Commitment - Bristol Myers Squibb.

To our employees. We embrace a diverse workforce and inclusive culture. The health, safety, professional development, work-life balance and equitable, respectful treatment of our employees are among our highest priorities. We commit to ensuring our colleagues have opportunities for development and advancement..

https://www.bms.com/about-us/our-company/our-mission.html.

Internships.

Develop U.S. GAAP technical accounting skills through on-the-job work with the Bristol Myers Squibb Technical Accounting Network (TAN). ... Our program can be the springboard to a fast-track position in our Human Resources Leadership Development program. 10- to 12-week summer internship ... Make a difference joining our team for the summer and ....

https://careers.bms.com/internships.

Research & Development Areas of Focus - Bristol Myers Squibb.

Innovative science is our passion. Transformational medicines are our goal. Bristol Myers Squibb is committed to discovering, developing and delivering transformational medicines in areas where we believe we have an opportunity to make a meaningful difference for patients: oncology, hematology, immunology, cardiovascular and fibrosis..

https://www.bms.com/researchers-and-partners/areas-of-focus.html.

Bristol Myers Squibb Careers.

Bristol Myers Squibb is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, protected veteran status, pregnancy, citizenship, marital status, gender expression, genetic information ....

https://careers.bms.com/.

Cell Therapy Resources - Bristol Myers Squibb.

As a company on the forefront of scientific innovation, Bristol Myers Squibb is evaluating new and next-generation cell therapies and investing in technology to optimize the sophisticated manufacturing process. Learn more about the science behind cell therapy and ongoing research at Bristol Myers Squibb..

https://www.bms.com/media/media-library/scientific-media-resources/cell-therapy.html.

Looking to the Future of Cell Therapy - Bristol Myers Squibb.

Nov 11, 2020 . Bristol Myers Squibb's cell therapy research team is uniquely equipped to gain insight into next-generation strategies in cell therapy. With ~1,800 patients treated across six indications and 11 manufacturing process variations, Bristol Myers Squibb scientists have access to one of the largest CAR T product portfolios in the industry ....

https://www.bms.com/life-and-science/science/looking-to-the-future-of-cell-therapy.html.

Bristol Myers Squibb Careers Job Search - Jobs.

Bristol Myers Squibb Careers.

https://careers.bms.com/jobs#!.

Bristol Myers Squibb Careers Job Search - Jobs.

Bristol Myers Squibb Careers.

https://careers.bms.com/jobs.

Leadership | Incyte.com.

Paula Swain joined Incyte in January 2002 and serves as Executive Vice President of Human Resources. Before joining the company, Ms. Swain spent nearly 10 years with DuPont (acquired by Bristol-Myers Squibb Company in 2001), where she served as Vice President and Senior Vice President of Human Resources..

https://www.incyte.com/our-company/our-leadership.

Clinical Trials & Studies - Bristol-Myers Squibb.

Bristol Myers Squibb believes that making clinical trial information available to patients, investigators and researchers, and physicians is a critical part of our commitment to transparency, scientific exchange and ultimately innovation. Learn more about our ....

https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html.

Bristol Myers Squibb (BMY) Q2 2022 Earnings Call Transcript.

1 day ago . Bristol Myers Squibb ... This reinforces our opportunity for leadership in cell therapy and further strengthens our view of Breyanzi as a key growth driver for the company with over 3 ....

https://www.fool.com/earnings/call-transcripts/2022/07/27/bristol-myers-squibb-bmy-q2-2022-earnings-call-tra/.

Independent Medical Education - Bristol Myers Squibb.

Our R&D team Researcher bios Research Publications "Golden Ticket" Contests ... People & Business Resource Groups leadership team Global Diversity and Inclusion Our Commitments Global Diversity and Inclusion Report ... For Bristol Myers Squibb to be seen as a worldwide leader in supporting innovative, high quality medical education that closes ....

https://www.bms.com/about-us/responsibility/IME.html.

Bristol Myers Squibb Buys Turning Point | San Diego Business ….

Jun 13, 2022 . Bristol Myers Squibb (BMS) is further strengthening its ties to San Diego. On June 3, the New York-based global biopharmaceutical company announced it had acquired Turning Point Therapeutics, Inc., a clinical-stage precision oncology company based in San Diego.The acquisition follows a March announcement by BMS that it would be moving into 427,000 ....

https://www.sdbj.com/news/2022/jun/13/bristol-myers-squibb-buys-turning-point/.

What To Expect From Bristol Myers Squibb Stock After Q2 Results?.

Jul 19, 2022 . Bristol Myers Squibb (NYSE: BMY) is scheduled to report its Q2 2022 results on Wednesday, July 27. We expect BMS to report revenue and earnings marginally above the consensus estimates..

https://www.forbes.com/sites/greatspeculations/2022/07/19/what-to-expect-from-bristol-myers-squibb-stock-after-q2-results/.

Bristol Myers Squibb launches initiative to ensure disability ….

Jul 21, 2022 . Bristol Myers Squibb (BMS) has launched the Disability Diversity in Clinical Trials (DDiCT) initiative to ensure equal access to clinical trials, ensuring all patient groups are 'reflective of the real-world population'. ... (DAWN) and will be co-led by DAWN and the Global Drug Development Team. Commenting on the launch, Tinamarie Duff ....

https://www.pmlive.com/pharma_news/bristol_myers_squibb_launches_initiative_to_ensure_disability_diversity_in_clinical_trials_1452484.

Bristol Myers Squibb Foundation Honors Diversity and Health ….

Apr 11, 2022 . The program, created as one of a number of commitments to health equity and diversity and inclusion made in 2020 by the BMSF and its donor Bristol Myers Squibb, has been named in honor of Robert A ....

https://www.businesswire.com/news/home/20220411005025/en/Bristol-Myers-Squibb-Foundation-Honors-Diversity-and-Health-Equity-Leader-By-Naming-Diversity-in-Clinical-Trials-Training-Program-After-Him-Welcomes-Gilead-Sciences-as-Program-Supporter.

Our Team - Engine Biosciences.

Dr. Trainor is a partner at BioMotiv which he joined after leaving Bristol Myers Squibb Company as Vice President of Oncology and Early Discovery Chemistry. At BMS George was responsible for all aspects of medicinal chemistry for the oncology area as well as hit-to-leads activities in support of all therapeutic areas..

https://www.enginebio.com/our-team/.

Best Stocks for 2022: Bristol-Myers Squibb Is Having a Great Year.

Jul 08, 2022 . And Bristol-Myers Squibb stock still has an above average dividend yield of 2.8%. This isn't the enviable 3%+ yield the stock offered 6 months ago, but it ....

https://www.nasdaq.com/articles/best-stocks-for-2022%3A-bristol-myers-squibb-is-having-a-great-year.

Bristol Myers Squibb - Bristol-Myers Squibb to Acquire Celgene to ....

Jan 03, 2019 . Bristol-Myers Squibb expects to realize run-rate cost synergies of approximately $2.5 billion by 2022. Bristol-Myers Squibb is confident it will achieve efficiencies across the organization while maintaining a strong, core commitment to innovation and delivering the value of the portfolio. Terms and Financing.

https://news.bms.com/news/details/2019/Bristol-Myers-Squibb-to-Acquire-Celgene-to-Create-a-Premier-Innovative-Biopharma-Company/default.aspx.

Bristol Myers Squibb’s Opdivo given NICE recommendation for ….

Jul 08, 2022 . Bristol Myers Squibb's Opdivo given NICE recommendation for urothelial cancer treatment ... Subscribe to our email news alerts. Featured jobs. Medical Writer, MRNA/ Covid 19, Medical Communications, UK ... MadMicrobe is an award-winning team of certified medical illustrators creating animations that engage your audience with immersive ....

https://www.pmlive.com/pharma_news/bristol_myers_squibbs_opdivo_given_nice_recommendation_for_urothelial_cancer_treatment_1451646.

News and Media - Bristol Myers Squibb.

Visit the Bristol Myers Squibb newsroom & stay up to date with our most current news as we continue to make a difference in the lives of our patients. ... Meet our Board and Leadership Team > Research Pipeline. Get an overview of our research focus and current pipeline..

https://www.bms.com/media.html.

Our Research and Development Locations - Bristol Myers Squibb.

Bristol Myers Squibb's Center for Innovation and Translational Research Europe (CITRE) R&D site in Seville, Spain is a capability center that brings together teams from our global Informatics and Predictive Sciences, early clinical development and Thematic Research Center organizations to contribute to Bristol Myers Squibb research efforts ....

https://www.bms.com/about-us/our-company/worldwide-facilities/our-research-facilities.html.

Omicron less likely to cause long COVID, UK study says.

Jun 17, 2022 . Bristol Myers Squibb Co said on Wednesday it had transferred its commercial operations in Russia to a third-party distributor and incurred $39 million in related costs..

https://www.reuters.com/business/healthcare-pharmaceuticals/omicron-less-likely-cause-long-covid-uk-study-2022-06-16/.

Nektar | Company | Our Leadership.

Our leadership team comprises pharmaceutical experts recognized for their contributions in drug development and success in bringing novel therapies to market. SEARCH. ... She serves as Nektar's strategic development leader for the company's clinical collaboration with Bristol-Myers Squibb. Prior to joining Nektar, Dr. Tagliarerri was a ....

https://www.nektar.com/company/our-leadership.